Nancy E. Dempze’s Thermo Fisher Scientific TMO Stock Holding History

Nancy E. Dempze’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-475	Closed	-$263K	–	105
2024 Q2	$263K	Buy	475 +20	+4%	+$11.5K	0.18%	69
2024 Q1	$264K	Sell	455 -6	-1%	-$3.37K	0.2%	55
2023 Q4	$245K	Hold	461	–	–	0.2%	52
2023 Q3	$233K	Sell	461 -61	-12%	-$32.5K	0.21%	58
2023 Q2	$272K	Hold	522	–	–	0.23%	57
2023 Q1	$301K	Sell	522 -4	-0.8%	-$2.25K	0.27%	53
2022 Q4	$290K	Buy	526 +25	+5%	+$13.2K	0.28%	54
2022 Q3	$254K	Hold	501	–	–	0.27%	55
2022 Q2	$272K	Hold	501	–	–	0.27%	58
2022 Q1	$296K	Hold	501	–	–	0.22%	68
2021 Q4	$334K	Sell	501 -10	-2%	-$6.24K	0.23%	66
2021 Q3	$292K	Sell	511 -5	-1%	-$2.74K	0.23%	65
2021 Q2	$261K	Buy	516 +51	+11%	+$24.1K	0.22%	62
2021 Q1	$213K	Sell	465 -10	-2%	-$4.77K	0.19%	66
2020 Q4	$221K	Hold	475	–	–	0.2%	63
2020 Q3	$210K	Buy	+475	New	+$196K	0.21%	65

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Nancy E. Dempze's TMO Position: Q3 2024 in Review

Nancy E. Dempze sold out of Thermo Fisher Scientific (TMO) in Q3 2024, closing a stake of 475 shares — an estimated $263K sold.

Nancy E. Dempze first reported a position in TMO in Q3 2020 and held it in 16 quarters. The position peaked at $334K in Q4 2021. 2,569 funds tracked by Wall St. Rank hold TMO as of Q3 2024.

Nancy E. Dempze reported no remaining Thermo Fisher Scientific position as of Q3 2024 after selling out during the quarter.
Nancy E. Dempze sold 475 Thermo Fisher Scientific shares in Q3 2024, an estimated $263K.
Nancy E. Dempze first reported a position in Thermo Fisher Scientific in Q3 2020 and held it in 16 quarters.
Nancy E. Dempze's Thermo Fisher Scientific position peaked at $334K in Q4 2021.
2,569 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2024.

Based on Nancy E. Dempze's 13F filing for Q3 2024, filed 12 Nov 2024.